Dana-Farber and Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA.
Biostatistics and Research Design Center, and.
Blood Adv. 2022 Jan 11;6(1):297-306. doi: 10.1182/bloodadvances.2021005539.
Shwachman-Diamond syndrome (SDS) is an inherited bone marrow failure syndrome with leukemia predisposition. An understanding of the hematologic complications of SDS with age could guide clinical management, but data are limited for this rare disease. We conducted a cohort study of 153 subjects from 143 families with confirmed biallelic SBDS mutations enrolled on the North American Shwachman Diamond Registry or Bone Marrow Failure Registry. The SBDS c.258 + 2T>C variant was present in all but 1 patient. To evaluate the association between blood counts and age, 2146 blood counts were analyzed for 119 subjects. Absolute neutrophil counts were positively associated with age (P < .0001). Hemoglobin was also positively associated with age up to 18 years (P < .0001), but the association was negative thereafter (P = .0079). Platelet counts and marrow cellularity were negatively associated with age (P < .0001). Marrow cellularity did not correlate with blood counts. Severe marrow failure necessitating transplant developed in 8 subjects at a median age of 1.7 years (range, 0.4-39.5), with 7 of 8 requiring transplant prior to age 8 years. Twenty-six subjects (17%) developed a myeloid malignancy (16 myelodysplasia and 10 acute myeloid leukemia) at a median age of 12.3 years (range, 0.5-45.0) and 28.4 years (range, 14.4-47.3), respectively. A lymphoid malignancy developed in 1 patient at the age of 16.9 years. Hematologic complications were the major cause of mortality (17/20 deaths; 85%). These data inform surveillance of hematologic complications in SDS.
Shwachman-Diamond 综合征(SDS)是一种具有白血病易感性的遗传性骨髓衰竭综合征。了解 SDS 随年龄增长的血液学并发症可以指导临床管理,但对于这种罕见疾病的数据有限。我们对 143 个确认存在双等位基因 SBDS 突变的家族中的 153 名受试者进行了队列研究,这些受试者来自北美 Shwachman Diamond 登记处或骨髓衰竭登记处。除了 1 名患者外,所有患者均存在 SBDS c.258+2T>C 变异。为了评估血细胞计数与年龄之间的关系,对 119 名受试者的 2146 次血细胞计数进行了分析。绝对中性粒细胞计数与年龄呈正相关(P<0.0001)。血红蛋白也与年龄呈正相关,直到 18 岁(P<0.0001),但此后呈负相关(P=0.0079)。血小板计数和骨髓细胞计数与年龄呈负相关(P<0.0001)。骨髓细胞计数与血细胞计数不相关。8 名受试者在中位年龄为 1.7 岁(范围为 0.4-39.5)时出现严重骨髓衰竭,需要移植,其中 7 名受试者在 8 岁之前需要移植。26 名受试者(17%)在中位年龄为 12.3 岁(范围为 0.5-45.0)和 28.4 岁(范围为 14.4-47.3)时分别发展为髓系恶性肿瘤(16 例骨髓增生异常和 10 例急性髓系白血病)。1 名患者在 16.9 岁时发生了淋巴恶性肿瘤。血液学并发症是主要的死亡原因(20 例死亡中的 17 例;85%)。这些数据为 SDS 中的血液学并发症监测提供了信息。